Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Clinical Pharmacokinetics|June 18, 2021
Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug ReactionsGeorgios Schoretsanitis, Ekkehard Haen, Daria Piacentino, et al.
Journal of Psychopharmacology (Oxford, England)|June 3, 2016
Pharmacokinetic considerations in the treatment of hypertension in risperidone-medicated patients - thinking of clinically relevant CYP2D6 interactionsMichael Paulzen, Ekkehard Haen, Gerhard Gründer, et al.
Pharmacopsychiatry|April 17, 2025
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson's Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysisNazar Kuzo, Marianna Piras, Ulrich C Lutz, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|January 21, 2020
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct DisordersDaria Piacentino, Georgios D Kotzalidis, Georgios Schoretsanitis, et al.
Journal of Clinical Psychopharmacology|November 5, 2016
Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined TreatmentGeorgios Schoretsanitis, Ekkehard Haen, Gerhard Gründer, et al.
European Journal of Clinical Pharmacology|April 2, 2010
Serum concentrations of paliperidone versus risperidone and clinical effectsYasmin Nazirizadeh, Friederike Vogel, Wolfgang Bader, et al.
CNS Drugs|July 4, 2013
Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendationsAnja Cerovecki, Richard Musil, Ansgar Klimke, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 18, 2017
Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychoticsMichael Paulzen, Georgios Schoretsanitis, Benedikt Stegmann, et al.
European Journal of Clinical Pharmacology|July 5, 2016
Pharmacokinetic patterns of risperidone-associated adverse drug reactionsGeorgios Schoretsanitis, Benedikt Stegmann, Christoph Hiemke, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 30, 2011
Implementation of a cost-effective HPLC/UV-approach for medical routine quantification of donepezil in human serumRalf Koeber, Hans-Hermann Kluenemann, Reinhold Waimer, et al.
Pageof 8